Annual Conference of IIHMR University Deliberated on AI for Global HealthIIHMR University Jaipur organised a two-day Global Health Management Research Conference on AI for Global Health: Innovation, Integration and Sustainability. The conference featured four thematic tracks: Transforming Community Health through AI and Behavioural Science Integration;
Mankind Pharma, India’s fourth-largest pharmaceutical company, has completed a large-scale, multi-year transformation of its global supply chain and strategic procurement function to strengthen access to medicines, improve supply reliability, and support disciplined, scalable growth. Delivered in collaboration with Accenture, the integrated initiative embeds digitally enabled
Indu Dhariwal, HR Manager, Iberia PharmaceuticalsThe pharma industry is at a turning point, despite being the world’s third-largest producer of medicines by volume. The sector was once defined by process stability and regulatory discipline, however, now it is being driven by innovation and technology. This
Novo Holdings, the global healthcare and life sciences investment firm that manages assets for the Novo Nordisk Foundation and is the controlling shareholder of Danish pharma major Novo Nordisk, has acquired a 49 % minority stake in India’s Surya Hospitals a leading women’s and children’s
Demonstrates leadership in AI driven pharma through Accenture partnershipBristol Myers Squibb, one of the world’s largestbiopharmaceutical companies, and Accenture, a global professional services firm, todayannounced the official opening of a new AI-powered content hub, ‘Mosaic’, in Mumbai,India.The first-of-its-kind, end-to-end, generative AI-enabled content hub will accelerateBristol
Event organized by Informa Markets in India to bring over 2,000 exhibitors & 50,000 industry participants from more than 120 countries under one roof.Organized by Informa Markets in India, the 18th edition of CPHI & PMEC India 2025, South Asia's largest and most influential pharmaceutical industry event, is scheduled
The evolving biosimilar regulations in the United States are poised to create new growth opportunities for Indian pharmaceutical companies, with experts predicting a significant uptick in exports and partnerships in the biopharma segment.The U.S. Food and Drug Administration’s (FDA) streamlined approval pathway for biosimilars, along
In a move to strengthen drug regulation and ensure the availability of safe, high-quality medicines, Uttar Pradesh Chief Minister Yogi Adityanath announced that the state government will double the number of drug inspectors across the state. The decision is aimed at improving the monitoring of
The Government of India has announced the launch of the PRIP (Promoting Research and Innovation in Pharma-MedTech) scheme, inviting proposals from industry players, startups, and research organizations for high-impact projects aimed at strengthening India’s pharmaceutical and medical technology ecosystem. The initiative is designed to accelerate
India’s healthcare stakeholders — including hospitals, diagnostic chains, medical device firms, insurers and pharma groups — have responded positively to the rollout of GST 2.0, saying the tax changes announced under Prime Minister Narendra Modi’s leadership will alleviate cost pressures, expand access, and give a
